Binu Thomas

Array ( [id] => 5436331 [patent_doc_number] => 20090170918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Solid Formulation of Fungicidal Mixtures' [patent_app_type] => utility [patent_app_number] => 12/066044 [patent_app_country] => US [patent_app_date] => 2006-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4173 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170918.pdf [firstpage_image] =>[orig_patent_app_number] => 12066044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6499007 [patent_doc_number] => 20100286193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Novel Azabicyclo[3.2.1]Oct-2-Ene Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/990015 [patent_app_country] => US [patent_app_date] => 2006-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7179 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286193.pdf [firstpage_image] =>[orig_patent_app_number] => 11990015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740732 [patent_doc_number] => 20080234385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Method For Inhibiting Tnf-Alpha' [patent_app_type] => utility [patent_app_number] => 11/997484 [patent_app_country] => US [patent_app_date] => 2006-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4988 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234385.pdf [firstpage_image] =>[orig_patent_app_number] => 11997484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4711707 [patent_doc_number] => 20080300233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Pharmaceutical Composition Comprising Simvastatin and Ezetimibe' [patent_app_type] => utility [patent_app_number] => 11/994782 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5413 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20080300233.pdf [firstpage_image] =>[orig_patent_app_number] => 11994782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4994213 [patent_doc_number] => 20070009558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Sugar-free storage-stable antihistaminic syrups' [patent_app_type] => utility [patent_app_number] => 11/477689 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3909 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20070009558.pdf [firstpage_image] =>[orig_patent_app_number] => 11477689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564756 [patent_doc_number] => 20090137609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'VITAMIN D-LIKE COMPOUND' [patent_app_type] => utility [patent_app_number] => 11/916955 [patent_app_country] => US [patent_app_date] => 2006-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 137688 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137609.pdf [firstpage_image] =>[orig_patent_app_number] => 11916955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5333471 [patent_doc_number] => 20090049935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Stabilized milnacipran formulation' [patent_app_type] => utility [patent_app_number] => 11/921888 [patent_app_country] => US [patent_app_date] => 2006-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16697 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20090049935.pdf [firstpage_image] =>[orig_patent_app_number] => 11921888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392323 [patent_doc_number] => 20090209636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Novel use of (-)-epigallocatechin gallate' [patent_app_type] => utility [patent_app_number] => 11/921657 [patent_app_country] => US [patent_app_date] => 2006-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8358 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209636.pdf [firstpage_image] =>[orig_patent_app_number] => 11921657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995205 [patent_doc_number] => 20070010550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Scopolamine to Reduce or Eliminate Hot Flashes, Night Sweats, and Insomnia' [patent_app_type] => utility [patent_app_number] => 11/421960 [patent_app_country] => US [patent_app_date] => 2006-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10020 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010550.pdf [firstpage_image] =>[orig_patent_app_number] => 11421960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625950 [patent_doc_number] => 20060264455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Use of huperzine for disorders' [patent_app_type] => utility [patent_app_number] => 11/439558 [patent_app_country] => US [patent_app_date] => 2006-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17544 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264455.pdf [firstpage_image] =>[orig_patent_app_number] => 11439558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214406 [patent_doc_number] => 08193212 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Use of huperzine for neuropathic pain' [patent_app_type] => utility [patent_app_number] => 11/439557 [patent_app_country] => US [patent_app_date] => 2006-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17546 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193212.pdf [firstpage_image] =>[orig_patent_app_number] => 11439557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515449 [patent_doc_number] => 20090215756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'FORMULATIONS CONTAINING LOSARTAN AND/OR ITS SALTS' [patent_app_type] => utility [patent_app_number] => 11/914828 [patent_app_country] => US [patent_app_date] => 2006-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3041 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215756.pdf [firstpage_image] =>[orig_patent_app_number] => 11914828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5527880 [patent_doc_number] => 20090197957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'Methods and compositions for the treatment of pain' [patent_app_type] => utility [patent_app_number] => 11/914442 [patent_app_country] => US [patent_app_date] => 2006-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14205 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197957.pdf [firstpage_image] =>[orig_patent_app_number] => 11914442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5890245 [patent_doc_number] => 20060276549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Combination and use of drugs' [patent_app_type] => utility [patent_app_number] => 11/432782 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15263 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276549.pdf [firstpage_image] =>[orig_patent_app_number] => 11432782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5687852 [patent_doc_number] => 20060286167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Compositions and methods for the treatment of neurodegenerative diseases' [patent_app_type] => utility [patent_app_number] => 11/415926 [patent_app_country] => US [patent_app_date] => 2006-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 8364 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20060286167.pdf [firstpage_image] =>[orig_patent_app_number] => 11415926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509204 [patent_doc_number] => 20090082411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Pharmaceutical for prevention or treatment of bone metabolic disease' [patent_app_type] => utility [patent_app_number] => 11/919003 [patent_app_country] => US [patent_app_date] => 2006-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7215 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082411.pdf [firstpage_image] =>[orig_patent_app_number] => 11919003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5850701 [patent_doc_number] => 20060233892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Topiramate compositions for treatment of headache' [patent_app_type] => utility [patent_app_number] => 11/406953 [patent_app_country] => US [patent_app_date] => 2006-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1480 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233892.pdf [firstpage_image] =>[orig_patent_app_number] => 11406953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968740 [patent_doc_number] => 08507551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Antimicrobial therapy for bacterial infections' [patent_app_type] => utility [patent_app_number] => 11/918584 [patent_app_country] => US [patent_app_date] => 2006-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 6 [patent_no_of_words] => 11929 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11918584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8932718 [patent_doc_number] => 08492418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Method of treating schizophrenia prodrome' [patent_app_type] => utility [patent_app_number] => 11/918287 [patent_app_country] => US [patent_app_date] => 2006-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15372 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11918287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5423057 [patent_doc_number] => 20090149513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Compositions of an Orally Active 1,2,4-Oxadiazole for Nonsense Mutation Suppression Therapy' [patent_app_type] => utility [patent_app_number] => 11/918114 [patent_app_country] => US [patent_app_date] => 2006-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18074 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149513.pdf [firstpage_image] =>[orig_patent_app_number] => 11918114 [rel_patent_id] =>[rel_patent_doc_number] =>)